Anthem Biosciences Ltd. carries a market capitalization of 434.79B, placing it among publicly traded companies globally.
| Market Cap | 434.79B |
| Enterprise Value | N/A |
Anthem Biosciences Ltd.'s stock has gained approximately 5.98343% over the past 52 weeks. The 50-day moving average sits at 772.98, while the 200-day moving average is 701.93.
| Beta (5Y) | N/A |
| 52-Week Price Change | 5.98343% |
| 50-Day Moving Average | 772.98 |
| 200-Day Moving Average | 701.93 |
| Average Volume (20 Days) | N/A |